For your patients with ADHD who are 6 years and older
Quillivant XR® delivers
His days may not be consistent but his medication should be.
Unique technology provides continuous delivery of methylphenidate through the day1
• Lasting improvements in attention and behavior2
Durable efficacy 12
hours postdose2,4,5
Smooth
PK profile3-5
Microtitration
with a liquid3
Request more information about Quillivant XR
Click below to sign up to receive more information about Quillivant XR.
You can also request a visit from a Tris Pharma representative.
ADHD, Attention Deficit Hyperactivity Disorder; ER, extended-release; PK, pharmacokinetic.
References: 1. Kando JC, King TR, Pardo A. A novel, modified-release drug delivery technology containing amphetamine and methylphenidate ion-exchange complexes. Poster presented at: American Psychiatric Association Annual Meeting; May 1-3, 2021. 2. Wigal SB, Childress AC, Belden HW, Berry SA. NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom study. J Child Adolesc Psychopharmacol. 2013;23(1):3-10. 3. Quillivant XR [package insert]. Tris Pharma, Inc., Monmouth Junction, NJ. 4. Childress AC, Berry SA. The Single-Dose Pharmacokinetics of NWP06, a Novel Extended-Release Methylphenidate Oral Suspension, Postgraduate Medicine. 2010; 122:5, 35-41, DOI: 10.3810/pgm.2010.09.2199 5. Childress AC, Sallee FR, Berry SA. Single-Dose Pharmacokinetics of NWP06, an Extended-Release Methylphenidate Suspension, in Children and Adolescents with ADHD, Postgraduate Medicine. 2011; 123:5, 80-88, DOI: 10.3810/pgm.2011.09.2462